The Unitary Enterprise "Pilot Production of the Institute of Bioorganic Chemistry" offers consumers rapid tests for the diagnosis of coronavirus infection under a manufacturing agreement and is seeking partners interested in a distribution services agreement.

Rapid test SARS-CoV-2-lgM/lgG is a rapid test for the detection of IgM and IgG antibodies to the SARS-CoV-2 coronavirus in human blood, serum and plasma using immunochromatographic analysis.

Rapid test SARS-CoV-2-antigen is a rapid test for the detection of the nucleocapsid antigen of the SARS-CoV-2 virus using immunochromatographic analysis.

Experience has shown that the diagnostic kits are competitive and are not inferior in properties to diagnostic kits from other manufacturers.

Information is posted in  Album of promising developments of the NAS of Belarus organizations for the real sector of the economy (2023), p. 195-196. (in Russian)

The purpose and characteristics of diagnostic kits can be found on the company's website in the section "Immunochromatographic rapid tests".
(in Russian)

Rapid tests are competitive in price.

The kits have technical characteristics that meet world standards.

The developed production technology is environmentally friendly, the kits have passed medical tests and state registration, and are approved for production, sale, and medical use.

The manufacturing and application technology meets modern requirements for medical products.

The production secrets (know-how) of express tests are presented in the form of technological instructions and technological regulations, which are protected as a commercial secret.

The Unitary Enterprise "Pilot Production of the Institute of Bioorganic Chemistry of the National Academy of Sciences of Belarus" was founded in 1986 as a specialized enterprise for the production of radioimmune kits for the diagnosis of various human diseases. Currently, it is a modern biotechnological enterprise with highly qualified personnel and a modern production and technical base that allows performing complex technological processes and producing high-quality products.

UE HOP IBOH NAS of Belarus" produces SARS-CoV-2-IgM/IgG Rapid Tests for the rapid detection of IgM and IgG antibodies to the SARS-CoV-2 coronavirus, which causes COVID-19.

Radioimmune kits are the main type of diagnostic products manufactured. They are intended for the diagnosis of thyroid diseases, assessment of the state of the reproductive system and endocrine-metabolic processes, and determination of tumor markers. The kits are equipped with solid-phase immunosorbents based on monoclonal antibodies and stabilized, ready-to-use liquid forms of standards and radioactively labeled drugs. In terms of analytical parameters and performance characteristics, these kits correspond to the best foreign analogues.

The enterprise, together with the Institute of Bioorganic Chemistry of the National Academy of Sciences of Belarus, develops and manufactures enzyme immunoassay kits of hormonal (for determining thyroid, steroid and pituitary hormones) and oncological profiles; kits based on lanthanide immunofluorometric analysis for prenatal and neonatal diagnostics.

The enzyme immunoassay kits of infectious profile produced by the enterprise on the basis of industrial cooperation are intended for diagnostics of syphilis, viral hepatitis B, C, ToRCH infections, AIDS and coronavirus.

The company has implemented and certified a quality management system for the production of in vitro diagnostic kits for compliance with the requirements of international standards ISO 9001 and ISO 13485.

The company is accredited as a scientific organization. Certificate of accreditation of a scientific organization dated 03/16/2023 No. 246.

Consumers interested in purchasing rapid tests for the diagnosis of coronavirus infection under a manufacturing agreement.

Partners interested in purchasing rapid tests for the diagnosis of coronavirus infection under a distribution services agreement.